相关实验视频
Updated: Jan 20, 2026

Primary Human Bronchial Epithelial Cells Grown from Explants
Published on: March 26, 2010
甲基伊索利诺/甲基伊索利诺对支气管上皮细胞中细胞毒性和线粒体功能障碍的影响
Eunah Lee1, Haeun Lee1, Yong Joo Park2
1School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon, 16419, Republic of Korea.
生物杀菌剂混合物CMIT/MIT (5-chloro-2-methyl-4-isothiazolin-3-one/2-methyl-4-isothiazolin-3-one) 通过破坏线粒体,损害呼吸道细胞. 这导致ROS,亡和自的增加.
科学领域:
- 毒理学 毒理学 毒理学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 在个人护理产品中常见的异构氨酸生物制剂,特别是CMIT/MIT.
- 目前尚不清楚CMIT/MIT混合物的呼吸道毒性.
- 人类支气管上皮细胞 (BEAS-2B) 是研究呼吸系统影响的相关模型.
研究的目的:
- 研究CMIT/MIT对人类支气管上皮细胞 (BEAS-2B) 的影响.
- 阐明CMIT/MIT引起的呼吸系统毒性的机制,重点关注线粒体通路.
- 检查CMIT/MIT对亡和自的影响.
主要方法:
- 用CMIT/MIT处理了BEAS-2B细胞.
- 评估了细胞活力.
- 评估了线粒体功能,包括复杂II活性,膜潜力和裂变/融合动态.
- 测量了反应性氧物种 (ROS) 水平,亡和自.
主要成果:
- 在暴露1小时后,CMIT/MIT表现出10μg/mL的细胞毒性.
- 线粒体复合体II被抑制,线粒体膜潜力下降.
- 线粒体动力学发生了变化,ROS水平增加,诱导了亡和自.
结论:
- 在人类支气管上皮细胞中,CMIT/MIT暴露会破坏线粒体功能.
- 线粒体损伤触发了细胞亡和自细胞死亡的途径.
- 这些发现强调了与CMIT/MIT暴露相关的潜在呼吸道风险.
更多相关视频
09:12Optimal Lentivirus Production and Cell Culture Conditions Necessary to Successfully Transduce Primary Human Bronchial Epithelial Cells
Published on: July 22, 2016
03:01alamarBlue Assay: A Sensitive Fluorometric Method to Screen the Cytotoxic Effects of Artificial Tear Formulations on Metabolic Activity of Human Corneal Epithelial Cells
相关概念视频
14:32Primary Human Bronchial Epithelial Cells Grown from Explants
09:12Optimal Lentivirus Production and Cell Culture Conditions Necessary to Successfully Transduce Primary Human Bronchial Epithelial Cells
03:01alamarBlue Assay: A Sensitive Fluorometric Method to Screen the Cytotoxic Effects of Artificial Tear Formulations on Metabolic Activity of Human Corneal Epithelial Cells
08:42Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
06:05An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives